PBE vs SPYM5YPBEPBEAvsBSPYMSPYMInvesco Biotechnology & Genome ETF · $441MState Street SPDR Portfolio S&P 500 ETF · $186BReturns · dividends in+21.9%3 years · per year$18,099 · $17,930+21.5%+6.2%5 years · per year$13,488 · $17,277+11.6%Cost and income0.59%Expense ratio$59 · $2 on $10k · lower wins0.02%1.36%
Overlap: PBE, SPYM, IVVToday99.9%most shared, SPYM and IVVPBESPYMIVVPBE—1.3%1.3%SPYM1.3%—99.9%IVV1.3%99.9%—End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus
PBE vs SPYM5YAPBEInvesco Biotechnology & Genome$13,488vsSPYMBSPDR Portfolio S&P 500$17,277$10k$15kNov 2021Nov 2026
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BSPYMState Street SPDR Portfolio S&P 500 ETFReadDesk0.02%1.03%−0.4%+11.5%+11.6%+21.5%+11.6%−8.9%$186.1B2IVViShares Core S&P 500 ETFReadDesk0.03%1.11%−0.4%+11.5%+11.6%+21.5%+11.5%−8.9%$879.1B3APBEInvesco Biotechnology & Genome ETFReadDesk0.59%1.36%−0.6%+20.5%+26.8%+21.9%+6.2%−11.7%$441MEnd-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BSPYMState Street SPDR Portfolio S&P 500 ETFReadDesk0.02%1.03%−0.4%+11.5%+11.6%+21.5%+11.6%−8.9%$186.1B2IVViShares Core S&P 500 ETFReadDesk0.03%1.11%−0.4%+11.5%+11.6%+21.5%+11.5%−8.9%$879.1B3APBEInvesco Biotechnology & Genome ETFReadDesk0.59%1.36%−0.6%+20.5%+26.8%+21.9%+6.2%−11.7%$441MEnd-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
SPYM vs SPYYTDSPDRSPYMSA+11.5%vsBSSPYSPDR+11.5%Jan 1Nov 13+11.5%+11.5%+11.5%Year to date+11.5%1.0%Yield1.0%$186BAssets$806B0–0levelEnd-of-day Nov 13, 2026
VOO vs IVVYTDVanguardVOOVA+11.5%vsBiSIVViShares+11.5%Jan 1Nov 13+11.5%+11.5%+11.5%Year to date+11.5%1.1%Yield1.1%$1.00TAssets$879B0–0levelEnd-of-day Nov 13, 2026
SCHD vs VIGYTDSchwabSCHDSA+34.9%vsBVVIGVanguard+16.0%Jan 1Nov 13+34.9%+16.0%+34.9%Year to date+16.0%2.9%Yield1.4%$124BAssets$109B2–0SCHD winsEnd-of-day Nov 13, 2026
Overlap: PBE, SPYM, IVVToday99.9%most shared, SPYM and IVVPBESPYMIVVPBE—1.3%1.3%SPYM1.3%—99.9%IVV1.3%99.9%—End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$108most kept, IVVIVV$111 − $3 = $108SPYM$103 − $2 = $101PBE$136 − $59 = $77KeptFeeEnd-of-day Nov 13, 2026 · yield in dollars minus the fee